Novant Health’s in-house attorneys have applied to modify a protective order as the Federal Trade Commission (FTC) questions its proposed $320 million acquisition of two North Carolina hospitals. The healthcare giant asserts the current order, which classifies almost the complete investigative file as confidential, as “unworkable”
This contention arises in light of Novant’s forthcoming merger challenge, which sees the crucial details of its investment plans subjected to intense scrutiny by the FTC. The protective order in question potentially inhibits Novant’s attorneys from accessing vital, confidential information, complicating their ability to respond adequately during the merger challenge proceedings.
Novant’s proposal could significantly impact its position within the healthcare industry, depending on the FTC’s ultimate findings and decisions. However, the company’s lawyers are continuing to seek avenues to ensure Novant’s interests are not undermined by a lack of access to necessary information. The outcome of this protective order modification request could set a precedent for future merger challenges amidst the ever-complex sphere of corporate law.